Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers esophageal Doppler Probes that is used to measure a patient's central vascular blood flow and fluid status to measure real time blood velocities within the descending aorta; Loops plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure waveform analysis algorithm used during periods of instability or for periods when the ODM mode is unavailable. The company also provides Deltex Medical Esophageal Doppler Simulator that enables clinicians to practice probe insertion, focusing, and waveform interpretation outside of a patient setting. Its products are used in Covid-19 critical care; sepsis; major abdominal, laparoscopic, and spinal surgeries; cardiac, trauma, and transplant procedures; and post-operative acute kidney injury monitoring. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom.

Deltex Medical Group plc

ExThera Medical develops blood filtration technologies, specifically the Seraph® 100 Microbind® Affinity Blood Filter for treating severe COVID-19 and the ONCObind™ Extracorporeal Procedure for treating metastatic cancer.

ExThera Medical

Elektro Schöffmann provides complete electrical and safety technology services. The company serves various industries including biotechnologies, healthcare facilities, and construction projects.

Elektro Schöffmann

Deltex Medical specializes in haemodynamic monitoring and offers solutions to combat haemodynamic instability in surgery and critical care. The company's technology aims to reduce complications such as acute kidney injury and respiratory distress.

Metric
Company Name	Deltex Medical Group plc	ExThera Medical	Elektro Schöffmann
Symbol	DEMG
MSH ID	COM:DELTEXMEDICAL	COM:EXTHERAMEDICAL	INFO:SCHOEFFMANN
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Commercial & Professional Services
Industry	Medical - Devices	Medical Devices	Construction and Electrical Services
Country	GB	US	DE
Stage
Employee Count	37
Website	deltexmedical.com	extheramedical.com	schoeffmann.info
LinkedIn
Founders

Metric
Market Cap	35.04K
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	2.26M
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.40M
EBITDA	-923.81K
Operating Income	-1.09M
Net Income	-1.60M
EPS	-0.00
Diluted EPS	-0.00
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.70
Operating Profit Margin	-0.40
EBITDA Margin	-0.41
Net Profit Margin	-0.43
Return on Equity	-0.42
Return on Assets	-0.17
Return on Capital Employed	-0.16

DEMG

COM:DELTEXMEDICAL

Deltex Medical

Last Close

0.08

25/11 08:00

Market Cap

27.49K

Beta: -

Volume Today

759.80K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-0.90
P/B Ratio	0.44
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.71
EV Multiple	0.00

Metric
Days Sales Outstanding	77.65
Days Payables Outstanding	967.28
Days Inventory Outstanding	424.80
Operating Cycle	500.62
Cash Conversion Cycle	349.42
Asset Turnover	0.40

Metric
Operating Cash Flow	-1.52M
Free Cash Flow	-1.99M
Cash Flow to Debt	-0.12
Operating Cash Flow/Sales	-0.11
Free Cash Flow Yield	-0.47

Metric
Cash & Equivalents	898.33K
Accounts Receivable	423.04K
Inventory	912.34K
Goodwill
Debt to Capitalization	0.53
Debt to Assets	0.32
Current Ratio	0.75
Quick Ratio	1.13

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.05
R&D to Revenue	0.09
SG&A to Revenue	0.63